Accolade price target raised to $14.50 from $12.50 at BofA

BofA analyst Michael Cherny raised the firm’s price target on Accolade to $14.50 from $12.50 and keeps a Neutral rating on the shares after having hosted a virtual investor meeting with Accolade’s CEO, CFO and Senior VP of Investor Relations. The firm sees a balanced risk/reward as it waits for continued execution on the path to profitability and cites better EBITDA visibility for its increased price target.